文献速递血管炎

巨细胞动脉炎患者的心血管疾病及其与血脂参数和内皮功能障碍的关联

Cardiovascular diseases and their associations with lipid parameters and endothelial dysfunction in giant cell arteritis.
PubMed 文献 · RMD Open · 2023-01-01

该研究纳入138例巨细胞动脉炎(GCA)患者和100例对照,2012年评估心血管疾病患病率、血脂、内膜中层厚度、动脉僵硬度及不对称/对称二甲基精氨酸,2020年通过病历回顾获取心血管事件、死亡和复发。GCA患者颈动脉和椎动脉疾病患病率更高,总胆固醇、低密度脂蛋白等水平更高,随访期间新发心血管事件更多。复发与未来心血管事件风险独立相关(OR 5.01,95%CI 1.55至16.22,p=0.007)。

要点

  • GCA患者颈动脉和椎动脉疾病患病率高于对照(p<0.001)。
  • GCA患者达标低密度脂蛋白目标者更少(p=0.001),随访新发心血管事件更多(p<0.001)。
  • 复发与未来心血管事件风险独立相关(OR 5.01,95%CI 1.55至16.22,p=0.007)。

核心结论

  • GCA患者发生心血管疾病的风险高,他汀类药物使用不足,且很大比例患者低密度脂蛋白胆固醇浓度高于高危患者治疗目标。
  • 这些数据强调需要改进预防策略以降低GCA患者的心血管风险。

研究设计与样本

  • 研究纳入138例GCA患者和100例对照,2012年评估心血管疾病患病率及相关指标,2020年通过病历回顾获取心血管事件、死亡和复发。

主要发现

  • GCA患者颈动脉和椎动脉疾病患病率高于对照(p<0.001)。
  • GCA患者总胆固醇、低密度脂蛋白、中密度脂蛋白、高密度脂蛋白、载脂蛋白A1和B及 augmentation index 水平均较高(所有p<0.05)。
  • GCA患者在研究入组时达到目标低密度脂蛋白水平者更少(p=0.001)。
  • GCA患者随访期间新发心血管事件更频繁且数量更多(所有p<0.001)。
  • GCA患者中他汀治疗与较低的不对称二甲基精氨酸、单核细胞和C反应蛋白水平相关(所有p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Evaluation of endothelial dysfunction, lipid metabolism, prevalence and development of cardiovascular diseases in patients with giant cell arteritis (GCA). METHODS: 138 GCA patients and 100 controls were evaluated for prevalent cardiovascular diseases in 2012. Cholesterol, lipoproteins and triglycerides, intima-media thickness, arterial stiffness, asymmetric and symmetric dimethylarginine were also measured in 2012. Cardiovascular events, mortality and relapse were retrieved by chart review in 2020. RESULTS: Prevalent carotid and vertebral artery disease was higher in GCA patients than in controls (p<0.001). GCA patients had higher levels of total cholesterol, low-density lipoprotein (LDL), intermediate-density lipoprotein, high-density lipoprotein, apolipoprotein A1 and B, and augmentation index (all with p<0.05). Target LDL levels were less frequently achieved at study inclusion by GCA patients (p=0.001), who developed more frequently new cardiovascular events, also with a higher amount, during follow-up (all with p<0.001). Statin treatment in GCA patients was associated with lower levels of asymmetric dimethylarginine, monocytes and C reactive protein (all with p<0.05). Relapse was independently associated with higher risk of future cardiovascular events (OR 5.01 (95% CI 1.55 to 16.22), p=0.007). CONCLUSIONS: GCA patients are at a high risk of developing cardiovascular diseases. Of relevance, there was underuse of statins and a large proportion of these patients showed LDL cholesterol concentrations above the treatment targets for high-risk patients. These data underscore the need for improvement of preventive strategies to reduce cardiovascular risk in GCA patients.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Jud P, Hafner F, Meinitzer A, et al. Cardiovascular diseases and their associations with lipid parameters and endothelial dysfunction in giant cell arteritis. RMD Open. 2023. PMID: 37657846. doi:10.1136/rmdopen-2023-003481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。